Literature DB >> 11971963

c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.

Kiyotsugu Yoshida1, Kiyoshi Komatsu, Hong-Gang Wang, Donald Kufe.   

Abstract

The ubiquitously expressed c-Abl tyrosine kinase is activated in the apoptotic response of cells to DNA damage. The mechanisms by which c-Abl signals the induction of apoptosis are not understood. Here we show that c-Abl binds constitutively to the mammalian homolog of the Schizosaccharomyces pombe Rad9 cell cycle checkpoint protein. The SH3 domain of c-Abl interacts directly with the C-terminal region of Rad9. c-Abl phosphorylates the Rad9 Bcl-2 homology 3 domain (Tyr-28) in vitro and in cells exposed to DNA-damaging agents. The results also demonstrate that c-Abl-mediated phosphorylation of Rad9 induces binding of Rad9 to the antiapototic Bcl-x(L) protein. The regulation of Rad9 by c-Abl in the DNA damage response is further supported by the demonstration that the interaction between c-Abl and Rad9 contributes to DNA damage-induced apoptosis. These findings indicate that Rad9 is regulated by a c-Abl-dependent mechanism in the apoptotic response to genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971963      PMCID: PMC133797          DOI: 10.1128/MCB.22.10.3292-3300.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Schizosaccharomyces pombe Rad9 contains a BH3-like region and interacts with the anti-apoptotic protein Bcl-2.

Authors:  K Komatsu; K M Hopkins; H B Lieberman; H Wang
Journal:  FEBS Lett       Date:  2000-09-15       Impact factor: 4.124

2.  X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.

Authors:  S W Muchmore; M Sattler; H Liang; R P Meadows; J E Harlan; H S Yoon; D Nettesheim; B S Chang; C B Thompson; S L Wong; S L Ng; S W Fesik
Journal:  Nature       Date:  1996-05-23       Impact factor: 49.962

3.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

Authors:  M Verheij; R Bose; X H Lin; B Yao; W D Jarvis; S Grant; M J Birrer; E Szabo; L I Zon; J M Kyriakis; A Haimovitz-Friedman; Z Fuks; R N Kolesnick
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

4.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling.

Authors:  Z Songyang; K L Carraway; M J Eck; S C Harrison; R A Feldman; M Mohammadi; J Schlessinger; S R Hubbard; D P Smith; C Eng
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

5.  Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.

Authors:  Z M Yuan; Y Huang; Y Whang; C Sawyers; R Weichselbaum; S Kharbanda; D Kufe
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

6.  The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.

Authors:  A B Raitano; J R Halpern; T M Hambuch; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  c-Abl activation regulates induction of the SEK1/stress-activated protein kinase pathway in the cellular response to 1-beta-D-arabinofuranosylcytosine.

Authors:  S Kharbanda; P Pandey; R Ren; B Mayer; L Zon; D Kufe
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

8.  Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents.

Authors:  S Kharbanda; R Ren; P Pandey; T D Shafman; S M Feller; R R Weichselbaum; D W Kufe
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

9.  The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.

Authors:  M Sattler; R Salgia; K Okuda; N Uemura; M A Durstin; E Pisick; G Xu; J L Li; K V Prasad; J D Griffin
Journal:  Oncogene       Date:  1996-02-15       Impact factor: 9.867

10.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.

Authors:  B J Druker; S Tamura; E Buchdunger; S Ohno; G M Segal; S Fanning; J Zimmermann; N B Lydon
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

View more
  34 in total

1.  c-Abl tyrosine kinase in the DNA damage response: cell death and more.

Authors:  V Meltser; M Ben-Yehoyada; Y Shaul
Journal:  Cell Death Differ       Date:  2011-01       Impact factor: 15.828

2.  Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.

Authors:  Kiyotsugu Yoshida; Tomoko Yamaguchi; Hirokuni Shinagawa; Naoe Taira; Keiichi I Nakayama; Yoshio Miki
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 3.  p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.

Authors:  Howard B Lieberman; Sunil K Panigrahi; Kevin M Hopkins; Li Wang; Constantinos G Broustas
Journal:  Radiat Res       Date:  2017-01-31       Impact factor: 2.841

4.  Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins.

Authors:  C L Meyerkord; Y Takahashi; R Araya; N Takada; R S Weiss; H-G Wang
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

5.  ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.

Authors:  Naoe Taira; Hiroyuki Yamamoto; Tomoko Yamaguchi; Yoshio Miki; Kiyotsugu Yoshida
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

6.  Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9.

Authors:  Kiyotsugu Yoshida; Hong-Gang Wang; Yoshio Miki; Donald Kufe
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

Review 7.  Contributions of Rad9 to tumorigenesis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

8.  MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.

Authors:  Deepak Raina; Rehan Ahmad; Shailendra Kumar; Jian Ren; Kiyotsugu Yoshida; Surender Kharbanda; Donald Kufe
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

9.  Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management.

Authors:  Howard B Lieberman; Alex J Rai; Richard A Friedman; Kevin M Hopkins; Constantinos G Broustas
Journal:  Transl Cancer Res       Date:  2018-01-14       Impact factor: 1.241

10.  The human Rad9 checkpoint protein stimulates the carbamoyl phosphate synthetase activity of the multifunctional protein CAD.

Authors:  Laura A Lindsey-Boltz; Eric M Wauson; Lee M Graves; Aziz Sancar
Journal:  Nucleic Acids Res       Date:  2004-08-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.